KHTRF:OTCMKTS
Knight Therapeutics Inc
US$7,58
0,00%
(0,00) 1D
US$7,51
arrow_downward
-0,94% (-0,071)todayPre-market
Closed: 9 ຕ.ລ., 15 ໂມງ 47 ນາທີ 48 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KHTRF...
Mkt. cap
1,05 ຕື້
Avg. vol.
1,32 ພັນ
Volume
4,40 ພັນ
52-wk high
US$7,63
52-wk low
US$4,07
Beta
0,20
Shares outstanding
98,23 ລ້ານ
No. of employees
830
Mkt. cap
1,05 ຕື້
Avg. vol.
1,32 ພັນ
Volume
4,40 ພັນ
52-wk high
US$7,63
52-wk low
US$4,07
Beta
0,20
Shares outstanding
98,23 ລ້ານ
No. of employees
830
News stories
From web sources and news partners
MarketBeat
·
24 ນາທີກ່ອນ
ProKidney (NASDAQ:PROK) Stock Price Down 6% - Here's Why
Seeking Alpha
·
53 ນາທີກ່ອນ
It Might Not Be Over Soon: A Decade Of Explosive Growth In The Options Market
Stocktwits
·
1 ຊົ່ວໂມງກ່ອນ
UNH Stock Outpaces S&P 500 In 2026, Eyes Best Year Since Pandemic — CFO Says Wall Street May Be Missing 2027 Upside
Yahoo Finance
·
1 ຊົ່ວໂມງກ່ອນ
Stock Market: Will S&P 500 Open Up or Down Today?
Profile
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
About Knight Therapeutics Inc
CEO-
Employees830
Founded2014
Headquartersມົງເລອານ, ແຂວງເກແບັກ, ແຄນາດາ
SectorPharmaceutical industry
Websiteknighttx.com